share_log

Vaccinex Shares Are Trading Lower. The Company Provided an Update on New Clinical Findings From Its SIGNAL-AD Phase 1b/2 Trial of Pepinemab Antibody in Alzheimer's Disease.

Vaccinex Shares Are Trading Lower. The Company Provided an Update on New Clinical Findings From Its SIGNAL-AD Phase 1b/2 Trial of Pepinemab Antibody in Alzheimer's Disease.

Vaccinex股價下跌。該公司就Pepinemab抗體在阿爾茨海默病SIGNAL-AD 1b/2期試驗中的新臨床發現進行了更新。
Benzinga ·  12:45

Vaccinex Shares Are Trading Lower. The Company Provided an Update on New Clinical Findings From Its SIGNAL-AD Phase 1b/2 Trial of Pepinemab Antibody in Alzheimer's Disease.

Vaccinex股價下跌。該公司就Pepinemab抗體在阿爾茨海默病SIGNAL-AD 1b/2期試驗中的新臨床發現進行了更新。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論